DeepMed Research

Northwestern University Human Resources

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1851-01-28

Employees: 5K

Market Cap: -

Website: https://www.venturecat.northwestern.edu

Clinical Trials

Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer

Phase 2

Completed

Conditions: Esophageal Cancer

Interventions: Drug: Induction Therapy - Capecitabine
Drug: Induction Therapy - Oxaliplatin
Drug: Combination Therapy - Capecitabine
Drug: Combination Therapy - Oxaliplatin
Radiation: Combination Therapy - Radiation
Procedure: Evaluation for response and surgery

First Posted Date: 2008-07-08

Last Posted Date: 2018-07-18

Lead Sponsor: Northwestern University

Target Recruit Count: 44

Registration Number: NCT00711412

Locations: 🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States

Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid Tumor

Phase 1

Completed

Conditions: Gastric Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Drug: docetaxel
Drug: fluorouracil
Drug: oxaliplatin

First Posted Date: 2008-07-08

Last Posted Date: 2019-02-26

Lead Sponsor: Northwestern University

Target Recruit Count: 59

Registration Number: NCT00711243

Locations: 🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States

Histological Characterization and Differentiation of Rash From Other Epidermal Growth Factor Receptor (EGFR) Inhibitors

Completed

Conditions: Skin Rash

Interventions: Procedure: Skin Biopsy of Skin Rash Secondary to EGFRI Use

First Posted Date: 2008-07-03

Last Posted Date: 2015-03-17

Lead Sponsor: Northwestern University

Target Recruit Count: 32

Registration Number: NCT00709878

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Effectiveness of Group Walking Sessions for Increasing Activity in People With Peripheral Arterial Disease (The Group Oriented Arterial Leg Study [GOALS])

Phase 3

Completed

Conditions: Peripheral Vascular Diseases
Cardiovascular Diseases

Interventions: Behavioral: Group mediated cognitive behavioral (GMCB) sessions
Other: Health education sessions

First Posted Date: 2008-06-09

Last Posted Date: 2015-10-29

Lead Sponsor: Northwestern University

Target Recruit Count: 194

Registration Number: NCT00693940

Locations: 🇺🇸
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States

Sorafenib-induced Hand- Foot Skin Reaction Treatment

Phase 2

Terminated

Conditions: Hand-foot Skin Reaction
Rash

Interventions: Drug: urea 40% cream
Drug: fluocinonide 0.05% cream
Drug: tazarotene 0.1% cream
Drug: bland emollient cream (Udderly smooth® Udder Cream)

First Posted Date: 2008-04-28

Last Posted Date: 2013-06-05

Lead Sponsor: Northwestern University

Target Recruit Count: 6

Registration Number: NCT00667589

Locations: 🇺🇸
Northwestern University Feinberg School of Medicine, Department of Dermatology, Chicago, Illinois, United States

Primary Care Community Partnerships to Prevent Diabetes

Not Applicable

Completed

Conditions: Hyperglycemia
Diabetes Mellitus
Obesity

Interventions: Behavioral: Dietitian Counseling Alone
Behavioral: Dietitian Plus Community Group Lifestyle

First Posted Date: 2008-04-11

Last Posted Date: 2018-03-29

Lead Sponsor: Northwestern University

Target Recruit Count: 509

Registration Number: NCT00656682

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Examining How Heart Disease Risk Factors Affect Healthy Aging (The Chicago Healthy Aging Study [CHAS])

Completed

Conditions: Coronary Disease
Cardiovascular Diseases

First Posted Date: 2008-02-29

Last Posted Date: 2023-05-03

Lead Sponsor: Northwestern University

Target Recruit Count: 1395

Registration Number: NCT00626379

Locations: 🇺🇸
Preventive Medicine Research Clinic, Chicago, Illinois, United States

T-Wave Alternans in Dialysis Patients

Completed

Conditions: Sudden Cardiac Death
End Stage Renal Disease

First Posted Date: 2008-02-22

Last Posted Date: 2015-03-12

Lead Sponsor: Northwestern University

Target Recruit Count: 40

Registration Number: NCT00621426

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

HLA-Identical Sibling Renal Transplant Tolerance

Not Applicable

Active, not recruiting

Conditions: Immunosuppression
Kidney Transplantation
Graft Rejection

Interventions: Biological: Infusion of Donor Hematopoietic Stem Cells and Campath-1H

First Posted Date: 2008-02-21

Last Posted Date: 2023-02-09

Lead Sponsor: Northwestern University

Target Recruit Count: 230

Registration Number: NCT00619528

Locations: 🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States

Supraphysiologic Insulin to Improve Outcomes After Surgical Treatment of Unruptured Cerebral Aneurysms

Not Applicable

Withdrawn

Conditions: Intracranial Aneurysm

Interventions: Drug: Insulin

First Posted Date: 2008-02-14

Last Posted Date: 2015-04-23

Lead Sponsor: Northwestern University

Registration Number: NCT00615381

Locations: 🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy